Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study

By Wright Jonathan  

Cancer Causes and Control, Vol. 20, Iss. 9, 2009-11 ,pp. : 1617-1622

Springer Publishing Company

Access to resources Recommend Favorite

Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study

By                      

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1208-1212

Science Publishers

Access to resources Recommend Favorite

Intermittent docetaxel chemotherapy is feasible for castration-resistant prostate cancer

By  

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 303-307

Science Publishers

Access to resources Recommend Favorite

The Risk of Malignant Tumours in First-degree Relatives of Men with Early Onset Prostate Cancer: A Population-based Cohort Study

By Bratt O.   Kristoffersson U.   Lundgren R.   Olsson H.  

European Journal of Cancer, Vol. 33, Iss. 13, 1997-11 ,pp. : 2237-2240

Elsevier

Access to resources Recommend Favorite

What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?

By Steineck Gunnar   Glimelius Bengt  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1589-1592

Informa Healthcare

Access to resources Recommend Favorite